Micrologix biotech Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Micrologix biotech

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Larry G. who wrote (604)	11/28/1999 12:31:00 PM
From: Sean Janzen	of 792

MBI management can only be viewed as brilliant if they can pull this off. I came across more definitive numbers regarding R&D costs of a drug in the 90's. "Based on a separate analysis by the Boston Consulting Group, the pre-tax R&D cost for drugs introduced in 1990 is $500 million." "Only three of ten marketed drugs produce revenues that match or exceed average R&D costs": searchforcures.com "One-third of company-financed R&D in the United States is devoted to evaluation of promising drug compounds in human clinical trials [Figure 2-5]. Phase I, II, and III trials, required for drug approval, account for 28 percent of R&D." searchforcures.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next